Sabra Health Care REIT stock carries a 6.1 percent yield
Sabra Health Care REIT's stock (SBRA) closed at USD 19.16 on October 2, 2026, offering a 6.1 percent annualized dividend yield despite a Q2 2026 diluted EPS loss of USD 0.10. While revenue grew 24.7 percent year-over-year, analysts maintain a "Moderate Buy" consensus with an average 12-month price target of USD 22.23, indicating potential upside for the stock which trades below its yearly high. The company's maintained FFO and AFFO guidance provides a positive outlook for investors.
Sabra Health Care REIT stock stood at EUR 17.25
Sabra Health Care REIT's stock was at EUR 17.25 on TradeGate as of September 25, 2026, with a market capitalization of USD 5.0 billion. Despite a 24.70% increase in Q2 2026 revenue, the company reported an earnings miss, while its FFO guidance for 2026 remains key for valuation. Analysts currently have a "Moderate Buy" consensus for the stock, with a 12-month target price above its Nasdaq price.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Rated "Moderate Buy" by Wall Street Brokerages
Sabra Healthcare REIT (NASDAQ:SBRA) has received a "Moderate Buy" rating from Wall Street brokerages, with seven out of fourteen analysts recommending a buy and the remaining seven suggesting a hold. The average 12-month price target is $22.23, exceeding its recent price of $19.77. Despite missing earnings expectations with a reported loss of ($0.10) per share, the company's quarterly revenue increased by 24.7% year-over-year to $230.11 million, and it maintains a high institutional ownership of 99.40%.
Sabra Healthcare REIT, Inc. $SBRA Stock Sold by Squarepoint Ops LLC
Squarepoint Ops LLC significantly reduced its holdings in Sabra Healthcare REIT (SBRA) by 93.6% in the second quarter, selling 157,633 shares and retaining 10,868 shares. Despite missing EPS estimates, Sabra's revenue rose 24.7% year-over-year, and the company maintains a quarterly dividend of $0.30 per share, reflecting a 6.1% annualized yield. Institutional investors hold 99.4% of SBRA, with analysts giving it a "Moderate Buy" rating and an average price target of $22.23.
NewEdge Advisors LLC Has $1.39 Million Position in Sabra Healthcare REIT, Inc. $SBRA
NewEdge Advisors LLC significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 261.2% in the second quarter, bringing its total holdings to 71,128 shares valued at $1.39 million. Institutional investors collectively own 99.4% of the company, which holds a "Moderate Buy" consensus rating from analysts with an average price target of $22.23. Despite missing EPS estimates, Sabra reported a 24.7% year-over-year revenue increase and recently paid a quarterly dividend of $0.30, yielding 6.1% annually.
Sabra Health Care REIT stock holds firm as income metrics stay in focus
Sabra Health Care REIT's stock is trading near $19.74, with a market capitalization of approximately $5.043 billion, reflecting its stable rental income from healthcare facilities. The company's focus on long-term leases in skilled nursing and senior housing provides consistent funds from operations, making it an income-oriented investment. While demographic trends support demand, interest rate movements and regulatory changes remain key risk factors.
Sabra Healthcare REIT (NASDAQ:SBRA) Share Price Passes Above Two Hundred Day Moving Average - Should You Sell?
Sabra Healthcare REIT (NASDAQ:SBRA) saw its shares briefly exceed its 200-day moving average, reaching $20.42 before closing at $20.15. The company reported a quarterly earnings miss but revenue beat expectations, and it maintains a $0.30 quarterly dividend despite a high payout ratio. Analysts have a "Moderate Buy" rating, and CEO Richard Matros recently sold a significant block of shares.
Sabra Healthcare REIT (NASDAQ:SBRA) Now Covered by Huntington
Huntington has initiated coverage on Sabra Healthcare REIT (NASDAQ:SBRA) with an "outperform" rating and a $23 price target, signaling a potential 10.6% upside. The company currently holds a consensus "Moderate Buy" rating from analysts, with an average price target of $22.23. Despite reporting mixed quarterly results—revenue exceeding estimates but adjusted EPS missing—and CEO Richard Matros selling a significant number of shares, the overall analyst sentiment remains positive.
Engineers Gate Manager LP Trims Position in Sabra Healthcare REIT, Inc. $SBRA
Engineers Gate Manager LP significantly reduced its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 55.5% during the second quarter, selling 1.31 million shares and retaining 1.05 million shares valued at $20.5 million. Despite this, institutional investors still hold 99.4% of SBRA's outstanding stock. Sabra reported quarterly revenue exceeding estimates but missed EPS forecasts, while maintaining a quarterly dividend of $0.30, representing a 5.8% yield.
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference
Sabra Health Care REIT, Inc. has released a business update for investors and will be participating in the BofA Securities 2026 Global Real Estate Conference. Key company executives, including the Chair and CEO Rick Matros and CFO Michael Costa, will represent Sabra at the event in New York from September 15-17, 2026. The company, a self-administered REIT, focuses on owning and investing in real estate for the healthcare industry across the U.S. and Canada.
CEO of Sabra (NASDAQ: SBRA) lines up $4.15M stock sale
Sabra Health Care REIT, Inc. (SBRA) CEO, Richard K. Matros, has filed a Rule 144 notice to sell up to 200,000 shares of common stock through Merrill Lynch, valued at $4.15 million. The sales are anticipated to commence around September 8, 2026, and are tied to Restricted Stock Units granted between 2013 and 2017. This filing indicates a planned disposal of shares by an insider, which is common as RSUs vest.
Sabra Health Care CEO Matros sells $4.17m in stock By Investing.com
Richard K. Matros, CEO of Sabra Health Care REIT, Inc. (NASDAQ:SBRA), sold 200,000 shares worth approximately $4.17 million on September 8, 2026, under a Rule 10b5-1 trading plan. Despite the sale, the stock is considered slightly undervalued with a 5.77% dividend yield and a 14.73% year-to-date return. The company recently reported mixed Q2 2026 results with revenue exceeding forecasts but an adjusted net loss, though normalized cash flows improved, leading to an upgraded rating from Raymond James.
Sabra Health Care CEO Matros sells $4.17m in stock
Richard K. Matros, CEO of Sabra Health Care REIT, Inc., sold 200,000 shares of company stock for approximately $4.17 million on September 8, 2026, pursuant to a pre-arranged trading plan. This transaction occurred amidst mixed financial results for Sabra Health Care in Q2 2026, where revenue beat expectations but the company reported an adjusted net loss due to a loan-loss provision. Despite this, management reaffirmed its full-year guidance, and Raymond James upgraded the stock to Market Perform.
Sabra Healthcare REIT (NASDAQ:SBRA) CEO Sells 200,000 Shares
Sabra Healthcare REIT (NASDAQ:SBRA) CEO Richard Matros sold 200,000 shares worth approximately $4.17 million, reducing his ownership by 10.77% to 1.66 million shares. The transaction, executed under a Rule 10b5-1 plan, occurred as the company reported a quarterly loss despite revenue growth. Analysts currently maintain a consensus "Hold" rating for SBRA with a price target of $22.17.
309,853 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al
Virginia Retirement Systems acquired 309,853 shares of Sabra Healthcare REIT (NASDAQ:SBRA) valued at approximately $6.05 million during the second quarter, bringing institutional ownership in the company to 99.40%. Despite reporting a 24.7% year-over-year revenue increase to $230.11 million, Sabra missed EPS estimates with a negative $0.10. The company maintains a quarterly dividend of $0.30 per share and analysts currently rate the stock as a "Hold" with an average price target of $22.17.
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has released a business update for investors and announced its participation in the BofA Securities 2026 Global Real Estate Conference. Key executives, including CEO Rick Matros, CFO Michael Costa, CIO Darrin Smith, and EVP of Finance Lukas Hartwich, will represent the company at the conference from September 15-17, 2026, in New York. Sabra is a real estate investment trust focused on the healthcare industry across the United States and Canada.
Hsbc Holdings PLC Boosts Holdings in Sabra Healthcare REIT, Inc. $SBRA
HSBC Holdings PLC significantly increased its stake in Sabra Healthcare REIT (SBRA) by 33.8% in the second quarter, now owning 676,554 shares valued at $13.3 million. Despite a quarterly loss of $0.10 per share, missing earnings estimates, the company's revenue rose 24.7% year-over-year to $230.1 million. Analysts have a "Hold" rating on SBRA, with a consensus price target of $22.17, and the REIT maintains a quarterly dividend of $0.30 per share, yielding 5.8%.
Readystate Asset Management LP Makes New $1.40 Million Investment in Sabra Healthcare REIT, Inc. $SBRA
Readystate Asset Management LP has made a new $1.40 million investment in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), acquiring 71,748 shares. Despite the new institutional investment and other hedge funds increasing their stakes, analyst sentiment for SBRA remains mixed, with a consensus "Hold" rating and an average price target of $22.17. The company reported quarterly revenue above estimates but missed EPS expectations, and it maintains a 5.8% dividend yield with a high payout ratio.
Headlands Technologies LLC Has $1.32 Million Position in Sabra Healthcare REIT, Inc. $SBRA
Headlands Technologies LLC significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 333.1% in the second quarter, bringing its total holdings to 67,486 shares valued at approximately $1.32 million. Institutional investors and hedge funds collectively own 99.4% of SBRA, indicating strong institutional interest. Despite mixed analyst ratings, the company maintains a "Hold" consensus with a target price of $22.17 and offers a 5.9% annualized dividend yield.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Rating of "Moderate Buy" by Brokerages
Sabra Healthcare REIT (NASDAQ:SBRA) has received a consensus "Moderate Buy" rating from thirteen brokerages, with an average 12-month price target of $22.27, exceeding its current share price of $20.61. Institutional investors hold a significant 99.40% stake and have recently increased their positions. Despite a 24.7% year-over-year revenue increase in its latest quarter, the company missed analyst earnings expectations and declared a quarterly dividend of $0.30 per share, resulting in a 5.8% yield.
Sabra Healthcare REIT (NASDAQ:SBRA) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened
Sabra Healthcare REIT (NASDAQ:SBRA) shares recently traded above their 200-day moving average, closing at $20.61 with a trading volume of over 1.6 million shares. Despite reporting a quarterly EPS of negative $0.10, missing estimates, the company saw a 24.7% year-over-year revenue increase and declared a quarterly dividend of $0.30 per share. Analyst sentiment remains largely positive, with a "Moderate Buy" consensus and an average price target of $22.27.
Sabra hits $100M in skilled nursing deals as base portfolio delivers reliable cash flow
Sabra Health Care REIT has invested $100 million in skilled nursing facilities this year, part of $600 million in total healthcare real estate investments, and expects another $100 million by year-end. The company's CEO, Rick Matros, highlighted strong operator performance, improved rent coverage, and favorable reimbursement environments as key drivers. Sabra maintains a selective approach to skilled nursing acquisitions, focusing on off-market deals and established operator partnerships, and has a flexible balance sheet to support future growth.
Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
Sabra Healthcare (SBRA) reported strong Q2 results, with funds from operations (FFO) of $0.4 per share, surpassing the Zacks Consensus Estimate of $0.39 per share, and revenues of $235.87 million, exceeding estimates by 3.87%. The company's stock has performed well this year, adding 11.8% compared to the S&P 500's 9.4% gain. While its FFO outlook for the coming quarters remains positive, the stock currently holds a Zacks Rank #3 (Hold).
Sabra Health Care REIT, Inc. (SBRA) Stock forecasts
Argus has lowered its target price for Sabra Health Care REIT Inc. (SBRA) to $21.00, with the current price at $20.15. The company operates as a healthcare facility real estate investment trust, focusing on owning and investing in healthcare real estate. This report from August 12, 2026, provides an updated outlook for the stock.
How Investors May Respond To Sabra Health Care REIT (SBRA) Profit Reversal And Steady Dividend
Sabra Health Care REIT (SBRA) recently reported a swing to a net loss of US$25.2 million in Q2 2026 despite increased revenue, while maintaining its quarterly dividend of US$0.30 per share. This situation raises questions about dividend coverage and financial flexibility, especially given the company's reliance on high dividend payouts amidst weaker profitability. Investors are encouraged to consider the implications of this mixed financial performance on the company's long-term investment narrative, particularly regarding its ability to sustain cash flows from senior housing and skilled nursing demand.
Quantinno Capital Management LP Grows Position in Sabra Healthcare REIT, Inc. $SBRA
Quantinno Capital Management LP significantly increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 424.3% in the first quarter, bringing its total to 155,086 shares worth $2.98 million. Institutional investors now collectively own 99.4% of SBRA's outstanding stock. Despite missing EPS estimates, Sabra reported a 24.7% year-over-year revenue increase and declared a quarterly dividend of $0.30, representing a 5.7% annualized yield.
California State Teachers Retirement System Grows Position in Sabra Healthcare REIT, Inc. $SBRA
The California State Teachers Retirement System increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 32.2% in the first quarter, now owning 298,653 shares valued at $5.74 million. Institutional investors hold 99.4% of the stock. Analysts have a "Moderate Buy" consensus rating with an average price target of $22.25, despite the company missing earnings expectations in its last quarterly report.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of "Moderate Buy" from Brokerages
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received a "Moderate Buy" consensus rating from 14 analysts, with an equal split of seven buy and seven hold ratings, and an average 12-month price target of $22.25. The company reported better-than-expected revenue of $230.11 million, a 24.7% year-over-year increase, but missed EPS estimates with a loss of $0.10. Sabra also declared a quarterly dividend of $0.30 per share, resulting in a 5.7% yield, and institutional investors hold approximately 99.4% of its stock.
Raymond James upgrades Sabra Healthcare stock on tenant transitions By Investing.com
Raymond James upgraded Sabra Healthcare REIT Inc. (NASDAQ:SBRA) stock to Market Perform from Underperform, citing successful tenant and operator transitions that offset a discounted loan payoff. The firm noted $21 million in recurring net operating income improvements and updated its fair value estimate to $23 per share. Sabra also reported mixed Q2 2026 results with a net loss but increased revenue and reaffirmed full-year guidance due to strong senior housing demand.
Sabra Health Care REIT, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SBRA) 2026-08-07
Sabra Health Care REIT, Inc. (SBRA) published its Q2 2026 earnings call presentation on August 7, 2026. The company reported an EPS of $0.15, missing estimates by $0.02, while revenue of $235.87 million beat estimates by $16.41 million, representing a 24.70% year-over-year increase. This presentation was released in conjunction with their earnings call.
Raymond James upgrades Sabra Healthcare stock on tenant transitions
Raymond James upgraded Sabra Healthcare REIT Inc. (NASDAQ:SBRA) stock from Underperform to Market Perform, citing the positive impact of preannounced tenant and operator transitions which offset a discounted loan payoff. The firm noted $21 million in recurring net operating income improvements from de-risking the behavioral health segment. Raymond James set a fair value estimate of $23 per share, highlighting Sabra's compelling 5.69% dividend yield and 16 years of consistent dividend payments.
Earnings call transcript: Sabra Health Care REIT misses Q2 2026 EPS, beats revenue
Sabra Health Care REIT reported missing its Q2 2026 EPS estimate but surpassed revenue expectations, reaffirming its upgraded full-year outlook. The company's portfolio is benefiting from stronger senior housing performance and strategic transitions, despite a wider-than-expected loss due to a large loan-loss provision. Management remains optimistic about sustained growth driven by senior housing demand and ongoing investment activity.
Sabra Health Care REIT, Inc. Q2 2026 Earnings Call Summary
Sabra Health Care REIT (SBRA) reported strong Q2 2026 performance, driven by growth in its managed senior housing portfolio and increased rent coverage in skilled nursing. The company reaffirmed its 2026 earnings guidance, anticipating low to mid-teens growth in same-store SHOP NOI, and highlighted strategic initiatives including potential divestment from the behavioral segment and significant balance sheet flexibility. Management also addressed non-recurring items like a loan loss provision and discussed the rationale behind value-add acquisitions and sustainable RevPOR growth.
Sabra Health Care REIT Q2 Revenue Beats Estimates, AFFO Rises to $0.40
Sabra Health Care REIT reported strong Q2 2026 results with revenue of $235.866 million, exceeding analyst estimates, and Normalized AFFO increasing to $0.40 per share. This performance was driven by a 13.7% growth in same-property senior housing Cash NOI, despite a GAAP net loss due to significant loan loss provisions of $102.4 million. The company also declared a quarterly cash dividend of $0.30 per share and maintained approximately $1.3 billion in liquidity.
Earnings call transcript: Sabra Health Care REIT misses Q2 2026 EPS, beats revenue
Sabra Health Care REIT (SBRA) reported a Q2 2026 adjusted net loss of $0.10 per share, missing estimates, but exceeded revenue forecasts with $235.87 million. The company reaffirmed its upgraded full-year guidance, driven by strong senior housing performance and strategic portfolio shifts towards managed senior housing. Management emphasized durable growth prospects, a healthy balance sheet, and consistent dividend payments, despite the one-time loan-loss provision impacting GAAP earnings.
Sabra Health Care Reports Q2 2026 Earnings Results
Sabra Health Care reported a net loss of $0.10 per diluted share for Q2 2026, with FFO at negative $0.02 and normalized AFFO at $0.40. Despite the disappointing results, the company reaffirmed its full-year 2026 guidance, aiming to maintain investor confidence, though its shares fell by 2.65% following the report. Analyst views are mixed, with some raising price targets due to portfolio optimization efforts, while others maintain a neutral stance.
Sabra Healthcare earnings test: Can portfolio shift offset headwinds? By Investing.com
Sabra Healthcare REIT Inc. is set to report second-quarter earnings, with investors focused on whether its portfolio transformation can sustain momentum after shares reached a five-year high. Analysts anticipate modest sequential EPS growth but a year-over-year decline, with revenue expected to slip slightly. The company recently announced significant portfolio reshaping, including re-tenanting Avamere properties and exiting a $300 million mortgage, leading to raised full-year guidance and a 9% stock surge.
Sei Investments Co. Raises Stock Position in Sabra Healthcare REIT, Inc. $SBRA
Sei Investments Co. significantly increased its stake in Sabra Healthcare REIT, Inc. by 28.2% in the first quarter, now owning 544,221 shares valued at approximately $10.5 million. Other institutional investors also adjusted their positions, with hedge funds and institutional investors collectively owning 99.4% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for Sabra Healthcare REIT, with a consensus price target of $22.25, following strong quarterly results that met EPS expectations and exceeded revenue estimates.
Dimensional Fund Advisors LP Grows Holdings in Sabra Healthcare REIT, Inc. $SBRA
Dimensional Fund Advisors LP significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 7.8% in the first quarter of 2026, now holding 3.73 million shares valued at $71.6 million. Sabra Healthcare REIT reported strong first-quarter earnings, matching analyst EPS estimates and exceeding revenue expectations with a 20.9% year-over-year increase. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $22.25.
First Trust Advisors LP Raises Holdings in Sabra Healthcare REIT, Inc. $SBRA
First Trust Advisors LP significantly increased its stake in Sabra Healthcare REIT, Inc. by 99.4% during the first quarter, now holding 750,633 shares valued at over $14.4 million. Other institutional investors also adjusted their positions, with notable increases from Principal Financial Group Inc., Lasalle Investment Management Securities LLC, Norges Bank, Sumitomo Mitsui Trust Group Inc., and Balyasny Asset Management L.P. The article also provides a financial overview of Sabra Healthcare REIT, including recent earnings, analyst ratings, and a consensus target price of $22.25, indicating a "Moderate Buy" rating.
Sabra Health Care REIT, Inc. (SBRA) Stock Forecasts
This article provides a stock forecast for Sabra Health Care REIT Inc. (SBRA) from Argus, dated July 29, 2026. Argus provides an earnings estimate and a current price of $22.05 for SBRA, which operates in the healthcare real estate sector. The company's full report and additional premium research features are available with an upgrade.
Healthcare of Ontario Pension Plan Trust Fund Has $11.29 Million Holdings in Sabra Healthcare REIT, Inc. $SBRA
The Healthcare of Ontario Pension Plan Trust Fund significantly increased its stake in Sabra Healthcare REIT, Inc. by 45.5% in the first quarter, now holding 587,253 shares valued at approximately $11.29 million. Institutional investors and hedge funds collectively own 99.4% of SBRA. Sabra Healthcare REIT reported strong first-quarter revenue of $211.74 million, up 20.9% year-over-year, with earnings per share matching analyst expectations at $0.16.
Public Employees Retirement System of Ohio Has $5.53 Million Position in Sabra Healthcare REIT, Inc. $SBRA
Public Employees Retirement System of Ohio significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 234.4% in the first quarter, now holding 287,522 shares valued at $5.53 million. This move reflects a broader trend of institutional investors adjusting their positions in the healthcare REIT. Analysts currently rate Sabra Healthcare REIT as a "Moderate Buy" with an average price target of $22.25.
Rush Island Management LP Purchases Shares of 1,598,287 Sabra Healthcare REIT, Inc. $SBRA
Rush Island Management LP has acquired 1,598,287 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), a stake valued at approximately $30.7 million, making it their 15th largest holding. Institutional ownership of Sabra Healthcare REIT remains high at 99.4%, with several major investors increasing their positions. The company reported strong quarterly revenue growth of 20.9% year-over-year, meeting earnings expectations, and analysts maintain a "Moderate Buy" rating with an average price target of $22.25.
Sabra Healthcare REIT (SBRA) to Announce Quarterly Earnings on Monday
Sabra Healthcare REIT (NASDAQ: SBRA) is expected to announce its Q2 2026 earnings on Monday, August 3rd, after market close, with analysts projecting $0.1711 EPS and $219.3870 million in revenue. The company's previous quarter saw it meet earnings estimates at $0.16 per share, while revenue surpassed expectations with 20.9% year-over-year growth to $211.74 million. Sabra Healthcare REIT currently holds a "Moderate Buy" rating from analysts with an average price target of $22.25.
BROOKFIELD Corp ON Invests $9.71 Million in Sabra Healthcare REIT, Inc. $SBRA
BROOKFIELD Corp ON has acquired a significant new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), purchasing over 500,000 shares valued at approximately $9.71 million. This investment highlights institutional confidence, with analysts giving SBRA a "Moderate Buy" rating and a consensus price target of $22.25. The real estate investment trust reported strong quarterly revenue growth and offers an attractive annual dividend yield of 5.4%.
Entropy Technologies LP Purchases 93,021 Shares of Sabra Healthcare REIT, Inc. $SBRA
Entropy Technologies LP significantly increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 299.6% in the first quarter, acquiring 93,021 additional shares. This institutional activity, which brought their total holdings to 124,068 shares valued at $2.386 million, is part of a broader trend of institutional investment in SBRA, with various firms like Vanguard Group and Principal Financial Group also adjusting their positions. Analyst ratings are mixed, with a consensus of "Moderate Buy" and an average price target of $22.25, while the company recently announced a quarterly dividend of $0.30 per share.
126,500 Shares in Sabra Healthcare REIT, Inc. $SBRA Purchased by Mizuho Markets Americas LLC
Mizuho Markets Americas LLC recently purchased 126,500 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) valued at approximately $2.43 million, establishing a new position in the company. Other institutional investors also adjusted their holdings in the REIT. Despite mixed analyst ratings, the consensus remains a "Moderate Buy" with an average price target of $22.25.
Militia Capital Management LLC Buys Shares of 46,000 Sabra Healthcare REIT, Inc. $SBRA
Militia Capital Management LLC has acquired 46,000 shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA), valued at approximately $885,000, initiating a new position in the company during the first quarter. This investment comes as Sabra Healthcare REIT reported Q1 EPS of $0.16 on $211.74 million in revenue, meeting analyst estimates, and declared a quarterly dividend of $0.30 per share. Analysts currently rate SBRA as a "Moderate Buy" with a consensus target price of $22.25.
Systematic Financial Management LP Sells 57,628 Shares of Sabra Healthcare REIT, Inc. $SBRA
Systematic Financial Management LP decreased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 2.6% in the first quarter, selling 57,628 shares and retaining 2,154,881 shares valued at $41.4 million. Despite this reduction, analyst sentiment remains a "Moderate Buy" with an average price target of $22.25. Sabra Healthcare REIT reported first-quarter EPS of $0.16, meeting estimates, with revenue up 20.9% year-over-year, and paid a quarterly dividend of $0.30, yielding 5.4%.
